Chesapeake Partners Management’s Allergan plc AGN Stock Holding History

Chesapeake Partners Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$23.1M	Sell	100,000 -100,000	-50%	-$23.1M	3.46%	9
2016 Q1	$53.6M	Hold	200,000	–	–	4.18%	6
2015 Q4	$62.5M	Buy	+200,000	New	+$59.5M	3.5%	3
2015 Q1	–	Sell	-150,000	Closed	-$38.6M	–	120
2014 Q4	$38.6M	Hold	150,000	–	–	1.47%	19
2014 Q3	$36.2M	Hold	150,000	–	–	1.33%	26
2014 Q2	$33.5M	Buy	+150,000	New	+$31.1M	1.01%	34

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Chesapeake Partners Management's AGN Position: Q2 2016 in Review

Chesapeake Partners Management increased its Allergan plc (AGN) stake by 15% in Q2 2016, buying an estimated $2.42M and bringing the position to 80,500 shares worth $18.6M. The position accounts for 2.78% of the portfolio, ranked #14.

Chesapeake Partners Management first reported a position in AGN in Q2 2013 and has held it in 11 quarters since. The position peaked at $58.1M in Q3 2014. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

Chesapeake Partners Management held 80,500 shares of Allergan plc worth $18.6M as of Q2 2016.
Chesapeake Partners Management bought 10,500 Allergan plc shares in Q2 2016, an estimated $2.42M.
Allergan plc made up 2.78% of Chesapeake Partners Management's portfolio in Q2 2016, its #14 holding.
Chesapeake Partners Management first reported a position in Allergan plc in Q2 2013 and has held it in 11 quarters since.
Chesapeake Partners Management's Allergan plc position peaked at $58.1M in Q3 2014.
1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Chesapeake Partners Management's 13F filing for Q2 2016, filed 15 Aug 2016.